CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 16, 2024 16:05 ET
|
CytoSorbents
PRINCETON, N.J., Aug. 16, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
CytoSorbents Reports Second Quarter 2024 Financial and Operational Results
August 13, 2024 16:19 ET
|
CytoSorbents
New CFO Peter J. Mariani to succeed retiring CFO Kathleen P. BlochOn track for DrugSorb™-ATR U.S. FDA De Novo and Health Canada marketing submissions this quarterIn Q2 2024, increased product sales by...
CytoSorbents Appoints Peter J. Mariani Chief Financial Officer
August 13, 2024 16:18 ET
|
CytoSorbents
PRINCETON, N.J., Aug. 13, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
CytoSorbents to Report Second Quarter 2024 Operating and Financial Results
August 07, 2024 07:00 ET
|
CytoSorbents
CytoSorbents to Report Q2 2024 Financial and Operating Results
CytoSorbents Announces Compliance with Nasdaq Minimum Bid Price Requirement
August 01, 2024 07:00 ET
|
CytoSorbents
CytoSorbents regains compliance with Nasdaq minimum bid price requirement
CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website
July 30, 2024 02:00 ET
|
CytoSorbents
CytoSorbents new modern website launch unifies corporate and product websites and highlights "Working to Save Lives Together"
CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website
July 29, 2024 08:00 ET
|
CytoSorbents
CytoSorbents new modern website launch unifies corporate and product websites and highlights "Working to Save Lives Together"
CytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health Congress
July 17, 2024 07:00 ET
|
CytoSorbents
CytoSorbents CEO Dr. Phillip Chan to highlight its innovative critical care and cardiac surgery blood purification therapy at AAPI Conference this weekend
CytoSorbents Secures $20 Million Credit Facility
July 02, 2024 07:00 ET
|
CytoSorbents
$20 million credit facility provides CytoSorbents with important non-dilutive capital to support its regulatory and commercialization objectives
CytoSorbents 公司宣布 CytoSorb® 獲得台灣監管部門批准
June 25, 2024 19:00 ET
|
CytoSorbents
新澤西州，普林斯頓, June 26, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO) 是透過其專屬的聚合物吸附技術使用血液淨化在深切治療部和心臟手術治療致命病症的領導者，現宣布CytoSorb®在台灣獲得食品藥物管理署 (TFDA)...